Oxcarbazepine for refractory epilepsy: Systematic review of the literature

Sao Paulo Medical Journal

Volumn 127, Issue 3, 2009, Pages 150-159

  Saconato, Humberto ^a,b   Do Prado, Gilmar Fernandes ^a   Puga, Maria Eduarda Dos Santos ^a   Atallah, Álvaro Nagib ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Anticonvulsants; Epilepsy; Oxcarbazepine substance name ; Review publication type ; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; OXCARBAZEPINE; PHENYTOIN; PLACEBO;

ADJUVANT THERAPY; ATTRIBUTABLE RISK; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; MORBIDITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; EPILEPSY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 70849099789     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802009000300008     Document Type: Review

References (27)

1. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470-472 (Pubitemid 40470667)
2. Smith PE; UK Oxcarbazepine Advisory Board. Clinical recommendations for oxcarbazepine. Seizure. 2001;10(2):87-91.
3. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47(7):1094-1120 (Pubitemid 44086745)
4. Schmidt D, Sachdeo R. Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use. Epilepsy Behav. 2000;1(6):396-405.
5. Schmidt D. How reliable is early treatment response in predicting long-term seizure outcome? Epilepsy Behav. 2007;10(4):588-594
6. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408-412
7. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from: http://www.cochrane.org/resources/handbook/ . Accessed in 2009 (Jun 24).
8. Christe W, Krämer G, Vigonius U, et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res. 1997;26(3):451-460 (Pubitemid 27146303)
9. Guerreiro MM, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27(3):205-213 (Pubitemid 27306801)
10. Kutluay E, McCaque K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4(2):175-180 (Pubitemid 37184590)
11. Passarella B, Nozzoli C. Long-term treatment with oxcarbazepine in clinical practice. Funct Neurol. 2005;20(3):131-133 (Pubitemid 43084989)
12. Albani F, Grassi B, Ferrara R, et al. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. Seizure. 2004;13(4):254-263 (Pubitemid 38607554)
13. Albani F, Bisulli F, Bartezaghi M, et al. Multicentre observational study evaluating immediate and progressive switching from carbamazepine to oxcarbazepine in patients with epilepsy. Funct Neurol. 2007;22(2):111-115 (Pubitemid 47249617)
14. Beydoun A, Sachdeo RC, Rosenfeld WE, et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology. 2000;54(12):2245-2251 (Pubitemid 30416274)
15. Beydoun A, Sachdeo RC, Kutluay E, McCague K, D'Souza J. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. Epilepsia. 2003;44(9):1160-1165 (Pubitemid 37100041)
16. Bill PA, Vigonius U, Pohlmann H. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 1997;27(3):195-204. (Pubitemid 27306800)
17. Piña-Garza JE, Espinoza R, Nordli D, et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology. 2005;65(9):1370-1375 (Pubitemid 41552763)
18. Sachdeo R, Beydoun A, Schachter S, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology. 2001;57(5):864-871 (Pubitemid 32845509)
19. Schachter SC, Vazquez B, Fisher RS, et al. Oxcarbazepine in a monotherapy trial for partial seizures-placebo-controlled studies in neurology: where do they stop? Neurology. 1999;53(9):2211-2212
20. Barcs G, Walker EB, Elger CE, et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia. 2000;41(12):1597-1607 (Pubitemid 32002734)
21. Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology. 2000;54(12):2237-2244
22. Reinikainen KJ, Keränen T, Halonen T, Komulainen H, Riekkinen PJ. Comparison of oxcarbazepine and carbamazepine: a double-blind study. Epilepsy Res. 1987;1(5):284-289 (Pubitemid 17162364)
23. Birbeck GL, Hays RD, Cui X, Vickrey BG. Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia. 2002;43(5):535-538
24. Zaccara G, Messori A, Cincotta M, Burchini G. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies? Acta Neurol Scand. 2006;114(3):157-168
25. Schmidt B. Clinical development of antiepileptic drugs in adults. Neurotherapeutics. 2007;4(1):62-69 (Pubitemid 46127464)
26. Schmidt D, Elger CE. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav. 2004;5(5):627-635
27. Vianna JBM. O teste oral de tolerância a glicose é freqüentemente alterado em pacientes com epilepsia de difícil controle. [Thesis] São Paulo: Universidade Federal de São Paulo - Escola Paulista de Medicina; 2006.